The race for a jab against Ebola is on. Three vaccines are now in development, with British scientists at the helm of clinical trials. The move comes as fears of a fresh outbreak grip Whitehall.
The Department for Health and Social Care is tight-lipped, but sources confirm the government has funneled millions into the programme. The trials are being fast-tracked. The usual regulatory hurdles have been lowered.
This is crisis mode, pure and simple. The WHO is watching closely. The labs are working around the clock.
The question is: will it be enough? The clock is ticking. And in the Lobby, the whispers are growing louder.
The PM's team is nervous. A successful vaccine could be a political goldmine. A failure would be catastrophic.
The science is sound, they insist. But in Westminster, science is just another battlefield.
